Key facts
- Senseye (Clinics/Outpatient Services)’s last known valuation is $50.0M (May 2022).
- It has raised $32.0M; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include Plug and Play Tech Center, Innovate UK, MedTech Innovator, Capital Factory, National Institutes of Health — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Senseye (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Senseye (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Senseye (Clinics/Outpatient Services)
Developer of a non-invasive mental health visibility platform intended to empower people to take charge of their mental health, powered by ocular biomarkers. The company's platform offers cognitive computing applications that are designed to show what the eyes provide to our brains to perceive the world and provide a window to the inner processes of the mind, enabling clinicians to provide personalized care to establish a clear baseline and track outcomes over time.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2015
- Employees
- 39
- Website
- senseye.co/
- Ownership
- Privately Held (backing)
Senseye (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Senseye (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Senseye (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.